TY - JOUR
T1 - Prognostic Interplay Between Coronary Artery Calcium Scoring and Cardiorespiratory FItness
T2 - The CAC-FIT Study
AU - Ahmed, Ahmed Ibrahim
AU - Saad, Jean Michel
AU - Han, Yushui
AU - Alfawara, Moath Said
AU - Soliman, Ahmed
AU - Nabi, Faisal
AU - Zoghbi, William A.
AU - Al-Mallah, Mouaz H.
N1 - Funding Information:
Dr Al-Mallah receives research support from Siemens, unrelated to this work. All other authors declare no relevant disclosures.
Publisher Copyright:
© 2022 Mayo Foundation for Medical Education and Research
PY - 2022/7
Y1 - 2022/7
N2 - Objective: To assess the incremental prognostic role of coronary artery calcium score (CACS) and exercise capacity (EC), two independent prognostic tests in the assessment of patients with coronary artery disease. Methods: The cohort consisted of patients who had clinically indicated exercise stress testing and CACS assessment from January 1, 2015, to September 30, 2021, with a median of 27 days between each other. Exercise capacity was defined by peak metabolic equivalents of task (METs) achieved during exercise stress test. The CACS was determined by the Agatston method. Patients were observed from the latest test date to incident major adverse cardiac events (inclusive of all-cause death, nonfatal myocardial infarction, late revascularization, and admission for heart failure). Results: There were a` total of 1932 patients in the study population (mean age, 56±12 years; 42% female, 48% hypertension, 21% diabetes, 48% dyslipidemia). Peak METs below 6 was achieved in 8% of patients, and the median (interquartile range) CACS was 9 (0-203). In multivariable Cox regression models, both CACS (1 unit increase in log CACS: hazard ratio, 1.19; 95% CI, 1.06 to 1.34; P=.003;) and EC (1 unit increase in peak METs: hazard ratio, 0.89; 95% CI, 0.81 to 0.97; P=.01) were independently associated with outcomes. Using CACS+EC added incremental prognostic value over clinical and fitness models (C index increase from 0.68 to 0.75; P=.015). Incident event rates increased across categories of CACS and EC. Conclusion: Our analysis found that CACS and EC have complementary risk-stratifying roles in coronary artery disease.
AB - Objective: To assess the incremental prognostic role of coronary artery calcium score (CACS) and exercise capacity (EC), two independent prognostic tests in the assessment of patients with coronary artery disease. Methods: The cohort consisted of patients who had clinically indicated exercise stress testing and CACS assessment from January 1, 2015, to September 30, 2021, with a median of 27 days between each other. Exercise capacity was defined by peak metabolic equivalents of task (METs) achieved during exercise stress test. The CACS was determined by the Agatston method. Patients were observed from the latest test date to incident major adverse cardiac events (inclusive of all-cause death, nonfatal myocardial infarction, late revascularization, and admission for heart failure). Results: There were a` total of 1932 patients in the study population (mean age, 56±12 years; 42% female, 48% hypertension, 21% diabetes, 48% dyslipidemia). Peak METs below 6 was achieved in 8% of patients, and the median (interquartile range) CACS was 9 (0-203). In multivariable Cox regression models, both CACS (1 unit increase in log CACS: hazard ratio, 1.19; 95% CI, 1.06 to 1.34; P=.003;) and EC (1 unit increase in peak METs: hazard ratio, 0.89; 95% CI, 0.81 to 0.97; P=.01) were independently associated with outcomes. Using CACS+EC added incremental prognostic value over clinical and fitness models (C index increase from 0.68 to 0.75; P=.015). Incident event rates increased across categories of CACS and EC. Conclusion: Our analysis found that CACS and EC have complementary risk-stratifying roles in coronary artery disease.
KW - Adult
KW - Aged
KW - Calcium/metabolism
KW - Cardiorespiratory Fitness
KW - Coronary Artery Disease
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Predictive Value of Tests
KW - Prognosis
KW - Risk Assessment
UR - http://www.scopus.com/inward/record.url?scp=85133250857&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133250857&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2022.03.032
DO - 10.1016/j.mayocp.2022.03.032
M3 - Article
C2 - 35787855
AN - SCOPUS:85133250857
SN - 0025-6196
VL - 97
SP - 1269
EP - 1281
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 7
ER -